CL-SAR Trademark

Trademark Overview


On Wednesday, February 21, 2024, a trademark application was filed for CL-SAR with the United States Patent and Trademark Office. The USPTO has given the CL-SAR trademark a serial number of 98415088. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, February 26, 2025. This trademark is owned by Soley Therapeutics, Inc.. The CL-SAR trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; downloadable computer software, namely, software for use in generating, analyzing, and accessing data via advanced computational techniques, automation, infrastructure, artificial intelligence, and machine learning; downloadable computer software for discovering drugs, forecasting potential uses of drug compounds and generating insights from screening and analyzing molecules, all using advanced computational techniques, automation, infrastructure, artificial intelligence, machine learning, computerized simulations, virtual screening, and generative chemistry; downloadable computer software for analyzing molecular data in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, ...

drug discovery services; research and development services in the field of pharmaceutical preparations; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via advanced computational techniques, automation, infrastructure, artificial intelligence, and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via advanc...
cl-sar

General Information


Serial Number98415088
Word MarkCL-SAR
Filing DateWednesday, February 21, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, February 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Goods and Servicesdownloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; downloadable computer software, namely, software for use in generating, analyzing, and accessing data via advanced computational techniques, automation, infrastructure, artificial intelligence, and machine learning; downloadable computer software for discovering drugs, forecasting potential uses of drug compounds and generating insights from screening and analyzing molecules, all using advanced computational techniques, automation, infrastructure, artificial intelligence, machine learning, computerized simulations, virtual screening, and generative chemistry; downloadable computer software for analyzing molecular data in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis for biotechnology and pharmaceutical companies; downloadable computer software for analyzing and generating insights from the sensing and response capabilities of cells; downloadable computer software for decoding cellular language; downloadable computer software for stain-free brightfield time-lapse imaging of cells
Goods and Servicesdrug discovery services; research and development services in the field of pharmaceutical preparations; providing online non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; providing online non-downloadable computer software for use in generating, analyzing, and accessing data via advanced computational techniques, automation, infrastructure, artificial intelligence, and machine learning; software as a service (SAAS) services featuring software for use in generating, analyzing, and accessing data via advanced computational techniques, automation, infrastructure, artificial intelligence, and machine learning; providing an online non-downloadable computer software platform for discovering drugs, forecasting potential uses of drug compounds and generating insights from screening and analyzing molecules, featuring software using advanced computational techniques, automation, infrastructure, artificial intelligence, machine learning, computerized simulations, virtual screening, and generative chemistry; software as a service (SAAS) services featuring software for discovering drugs, forecasting potential uses of drug compounds and generating insights from screening and analyzing molecules, all using advanced computational techniques, automation, infrastructure, artificial intelligence, machine learning, computerized simulations, virtual screening, and generative chemistry; providing an online non-downloadable computer software platform for analyzing molecular data in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis for biotechnology and pharmaceutical companies; software as a service (SAAS) services featuring software for analyzing molecular data in the fields of genetics, genomics, phenomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis for biotechnology and pharmaceutical companies; providing an online non-downloadable computer software platform for analyzing and generating insights from the sensing and response capabilities of cells; software as a service (SAAS) services featuring software for analyzing and generating insights from the sensing and response capabilities of cells; providing online non-downloadable computer software for decoding cellular language; software as a service (SAAS) services featuring software for decoding cellular language; providing online non-downloadable computer software for stain-free brightfield time-lapse imaging of cells; software as a service (SAAS) services featuring software for stain-free brightfield time-lapse imaging of cells; preclinical drug discovery services used for identifying, designing, and optimizing chemical compounds; pharmaceutical product evaluation and preclinical evaluation of chemical series and chemical compounds in drug discovery via software using artificial intelligence; preclinical pharmaceutical drug development services used for identifying, designing, and optimizing chemical compounds; pharmaceutical drug development and discovery services, namely, identifying, designing, optimizing, and developing chemical series and chemical compounds via software using advanced computational techniques, automation, infrastructure, artificial intelligence, machine learning, computational modeling, high-throughput screening, medicinal chemistry, biology, pharmacology, computerized simulations, virtual screening, and generative chemistry; providing an online searchable database in the fields of pharmaceuticals for scientific research purposes, in particular, pharmaceutical research and development, scientific research and development of pharmaceutical preparations, scientific development of new uses for pharmaceutical compounds, and scientific technical research; scientific research and development for scientific purposes, namely forecasting the use of molecules as drug compounds and developing new uses for pharmaceutical compounds; research and development in the field of drug discovery and development, molecular screening, cellular screening, phenomics, genetics, genomics, biology, chemistry, molecular biology, pathology, phenotypic sciences, omics, and image-based analysis; drug discovery services, namely, phenotypic screening services for discovering novel molecules to develop into drug compounds

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, February 21, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 21, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSoley Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080

Party NameSoley Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, February 21, 2024NEW APPLICATION ENTERED
Thursday, June 27, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 17, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Tuesday, September 17, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 26, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 26, 2025SOU EXTENSION 1 FILED
Wednesday, February 26, 2025SOU EXTENSION 1 GRANTED
Thursday, February 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED